483
Sciegen Pharmaceuticals IncFDA 483 - Sciegen Pharmaceuticals Inc - September 16, 2011
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Sciegen Pharmaceuticals Inc. in Hauppauge, NY, was cited with two observations during a pre-approval inspection. The firm lacked scientifically sound laboratory controls for assigning expiry periods to volumetric solutions without stability data. Additionally, procedures were not established to prevent objectionable microorganisms, specifically concerning the purified water system's delivery hose.
Open in Dashboard
ID · 1d284827-ee38-4511-b570-a5c012157fbc